more...
more...
Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel.
Pfizer to Acquire Serenex to Extend Oncology Pipeline and Access Novel Technology Platform.
Paragon Technologies Co., Ltd. completed a successful initial public offering.
Serenex raises $31 million.
Broadcom would acquire Global Locate, Inc.
About Us  ∣  Team  ∣  Portfolio  ∣  News  ∣  Contact Us

Copyright 2000-2008 PAC-LINK Management Corp.  All rights reserved. Various trademarks held by their respective owners.